Published in Atherosclerosis on March 01, 1990
Cardiac valve surgery--the "French correction". J Thorac Cardiovasc Surg (1983) 5.82
Orbital and millennial Antarctic climate variability over the past 800,000 years. Science (2007) 5.10
Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. Antimicrob Agents Chemother (1987) 4.00
Reconstructive surgery of mitral valve incompetence: ten-year appraisal. J Thorac Cardiovasc Surg (1980) 2.97
EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis (2009) 2.76
High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology (1993) 2.65
Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology (2007) 2.52
Endoscopic coronary artery bypass grafting with the aid of robotic assisted instruments. J Thorac Cardiovasc Surg (1999) 2.46
A new reconstructive operation for correction of mitral and tricuspid insufficiency. J Thorac Cardiovasc Surg (1971) 2.32
Cardiac troponin I: its contribution to the diagnosis of perioperative myocardial infarction and various complications of cardiac surgery. Crit Care Med (2001) 2.26
Cardiac valve papillary fibroelastoma: surgical excision for revealed or potential embolization. J Thorac Cardiovasc Surg (1999) 2.24
Very long-term results (more than 20 years) of valve repair with carpentier's techniques in nonrheumatic mitral valve insufficiency. Circulation (2001) 2.20
Cellular therapy reverses myocardial dysfunction. J Thorac Cardiovasc Surg (2001) 2.16
Impact of pain in health related quality of life of patients with systemic sclerosis. Rheumatology (Oxford) (2006) 2.15
Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann Rheum Dis (2004) 2.06
Biological factors affecting long-term results of valvular heterografts. J Thorac Cardiovasc Surg (1969) 2.04
Reconstitution of a functional membrane enzyme system in a monomolecular film. I. Formation of a mixed monolayer of lipopolysaccharide and phospholipid. J Mol Biol (1970) 1.90
The surgical treatment of constrictive fibrous endocarditis. Ann Surg (1976) 1.81
A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper. Mult Scler (2012) 1.74
The aorta-to-coronary radial artery bypass graft. A technique avoiding pathological changes in grafts. Ann Thorac Surg (1973) 1.71
Studies on bluetongue. V. Detection of the virus in infected materials by immunofluorescence. Can J Comp Med Vet Sci (1967) 1.68
Imipenem/vancomycin for Rhodococcus equi pulmonary infection in HIV-positive patient. Lancet (1991) 1.66
Sulbactam/ampicillin: in vitro spectrum, potency, and activity in models of acute infection. Rev Infect Dis (1987) 1.64
Studies on bluetongue. 3. Comparison of two complement-fixation methods. Can J Comp Med Vet Sci (1967) 1.64
Homograft replacement of the mitral valve. Graft selection, technique of implantation, and results in forty-three patients. J Thorac Cardiovasc Surg (1996) 1.60
Very late heart transplant rejection is associated with microvascular injury, complement deposition and progression to cardiac allograft vasculopathy. Am J Transplant (2011) 1.57
Effects of caffeine and chlorogenic acid on propidium iodide accessibility to DNA: consequences on genome size evaluation in coffee tree. Ann Bot (2003) 1.57
Monoclonal and oligoclonal gammopathies in heart-transplant recipients. Clin Chem (1991) 1.54
Simultaneous determination of serum neopterin and C-reactive protein as markers of infection in heart-transplant recipients. Clin Chem (1989) 1.52
Left ventricular outflow tract obstruction after mitral valve repair. Results of the sliding leaflet technique. Circulation (1993) 1.52
HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum. Arterioscler Thromb Vasc Biol (1997) 1.51
The radial artery for coronary artery bypass grafting: clinical and angiographic results at five years. J Thorac Cardiovasc Surg (1998) 1.49
Valve repair with Carpentier techniques. The second decade. J Thorac Cardiovasc Surg (1990) 1.49
Comparison of the acute hemodynamic effects of hypertonic or colloid infusions immediately after mitral valve repair. Crit Care Med (1999) 1.48
Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (2011) 1.46
Efficacy and tolerance of gastrostomy feeding in Duchenne muscular dystrophy. Clin Nutr (2009) 1.45
Updating the H-antigen classification of Bacillus thuringiensis. J Appl Microbiol (1999) 1.44
Effects of respiration on blood pressure and heart rate variability in humans. Clin Exp Pharmacol Physiol (1991) 1.43
Peripheral vascular involvement in heart transplant patients. Ann Vasc Surg (1994) 1.43
Angiographic and electron-beam computed tomography studies of retrograde cardioplegia via the coronary sinus. J Thorac Cardiovasc Surg (1996) 1.43
A simple and highly sensitive radioenzymatic assay for lysophosphatidic acid quantification. J Lipid Res (2000) 1.42
Nonsteroidal antiinflammatory drug-induced colitis and misoprostol. Dig Dis Sci (1996) 1.42
Congenital malformations of the mitral valve in children. Pathology and surgical treatment. J Thorac Cardiovasc Surg (1976) 1.42
2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working group. Ann Oncol (2009) 1.41
[Ascending aortic ectasia. New reinforcement technique]. Presse Med (1991) 1.39
[Chronic meningitis before diagnosis of celiac disease]. Rev Neurol (Paris) (2002) 1.39
Early extubation after mitral valve surgery: a target-controlled infusion of propofol and low-dose sufentanil. J Cardiothorac Vasc Anesth (1997) 1.38
Effect of systemic hypertension on renal function and left ventricular hypertrophy in heart transplant recipients. J Am Coll Cardiol (1990) 1.38
Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant (2005) 1.37
CD28 expression in T cell aging and human longevity. Exp Gerontol (1998) 1.36
Studies on bluetongue. VI. Animal transmission studies. Can J Comp Med Vet Sci (1967) 1.36
Correspondence between functional magnetic resonance imaging somatotopy and individual brain anatomy of the central region: comparison with intraoperative stimulation in patients with brain tumors. J Neurosurg (2000) 1.35
Six-year follow-up of glutaraldehyde-preserved heterografts. With particular reference to the treatment of congenital valve malformations. J Thorac Cardiovasc Surg (1974) 1.35
Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. J Clin Invest (1999) 1.35
Long-term (29 years) results of reconstructive surgery in rheumatic mitral valve insufficiency. Circulation (2001) 1.34
Initial chemotherapy in gliomatosis cerebri. Neurology (2004) 1.33
Surgical treatment of constrictive fibrous endocarditis. J Thorac Cardiovasc Surg (1981) 1.32
Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc Natl Acad Sci U S A (2001) 1.32
Reliable flow cytometric estimation of nuclear DNA content in coffee trees. Cytometry (1996) 1.31
Clinical performance with the Levitronix Centrimag short-term ventricular assist device. J Heart Lung Transplant (2006) 1.30
Studies on bluetongue. IV. Studies of three strains in primary bovine foetal kidney cell cultures. Can J Comp Med Vet Sci (1967) 1.30
Aortic root replacement with a composite graft. Factors influencing immediate and long-term results. Eur J Cardiothorac Surg (1996) 1.29
Combined coronary and femoral revascularization using an ascending aorta to bifemoral bypass. Arch Surg (1994) 1.28
Allogeneic hematopoietic SCT for patients with autoimmune diseases. Bone Marrow Transplant (2009) 1.28
Left ventricular outflow obstruction after mitral valve repair (Carpentier's technique). Proposed mechanisms of disease. Circulation (1988) 1.27
Conservative management of the prolapsed mitral valve. Ann Thorac Surg (1978) 1.27
In vitro activity of CP-65,207, a new penem antimicrobial agent, in comparison with those of other agents. Antimicrob Agents Chemother (1989) 1.27
[Fibrous endocarditis of the left ventricle in a patient with filariasis; surgical cure]. Arch Mal Coeur Vaiss (1973) 1.25
[Open heart operation under videosurgery and minithoracotomy. First case (mitral valvuloplasty) operated with success]. C R Acad Sci III (1996) 1.22
International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer. J Thromb Haemost (2013) 1.21
Aortic dissection. Prevalence, cause, and results of late reoperations. J Thorac Cardiovasc Surg (1994) 1.21
Clinical outcome following lung transplantation in patients with cystic fibrosis colonised with Burkholderia cepacia complex: results from two French centres. Thorax (2008) 1.20
Update on counterfeit antibiotics worldwide; public health risks. Med Mal Infect (2012) 1.20
A comparison of some serological tests for bluetongue virus infection. Can J Comp Med (1976) 1.20
Skin involvement in scleroderma--where histological and clinical scores meet. Rheumatology (Oxford) (2007) 1.20
A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer. Arterioscler Thromb (1994) 1.19
Birth weight and sex ratio after transfer at the blastocyst stage in humans. Fertil Steril (1999) 1.18
Management of hydrocephalus in pediatric patients with posterior fossa tumors: the role of endoscopic third ventriculostomy. J Neurosurg (2001) 1.18
Cold cerebroplegia. A new technique of cerebral protection during operations on the transverse aortic arch. J Thorac Cardiovasc Surg (1991) 1.18
Seroepidemiological survey of maedi-visna virus infection in sheep and goat flocks in Quebec. Can J Comp Med (1983) 1.17
Limited surgical approach for explanting the HeartMate II left ventricular assist device after myocardial recovery. J Thorac Cardiovasc Surg (2008) 1.14
Portal venous and enteric exocrine drainage versus systemic venous and bladder exocrine drainage of pancreas grafts: clinical outcome of 40 consecutive transplant recipients. Ann Surg (2000) 1.14
Correlations between molecular profile and radiologic pattern in oligodendroglial tumors. Neurology (2004) 1.14
Computer-assisted cardiac surgery. Lancet (1999) 1.13
Double mitral homograft for recurrent bacterial endocarditis of the mitral and tricuspid valves. J Heart Valve Dis (1994) 1.13
Differential effects of monounsaturated, polyunsaturated and saturated fat ingestion on glucose-stimulated insulin secretion, sensitivity and clearance in overweight and obese, non-diabetic humans. Diabetologia (2006) 1.12
Valve extension with glutaraldehyde-preserved autologous pericardium. Results in mitral valve repair. J Thorac Cardiovasc Surg (1991) 1.12
Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes. Diabetes Metab (2009) 1.12
The metabolic syndrome. Pathol Biol (Paris) (2006) 1.12